Armand Armstead, who played for the U.S.C. Trojan's, resolved a lawsuit filed against the University which alleged that the school misused a pain medication, Taradol, which resulted in Armstead suffering multiple heart attacks.
According to the news report, this pain killer has been found to possibly cause an increased risk of serious cardiovascular issues. The settlement terms were kept confidential, but unfortunately for Armstead, the effects of the pain medication will prevent him from pursuing a professional athletic career.
The lawsuit, which is a public document, claimed that the U.S.C. medical personnel injected Armstead up to 11 different occasions to relieve shoulder injury symptoms two days before a scheduled game. Armstead compiled depressive statistics his junior year, but was never cleared to play his senior season due to an undisclosed injury.
The physician who administered the injections testified in a deposition, and told attorneys that he disagreed with the FDA warnings that the drug increase the risk of cardiac problems. The physician cited the fact that he had been injecting players with Toradol for 15 years without incident.
After leaving U.S.C., Armstead spent one season in the Canadian Football League, earning all-star honors and a title. He then moved on to the NFL, but did not play and other game. Finally, before the 2014 injury, Armstead announced his retirement at the ripe age of 23.